Viking Holdings stock is cruising higher in its debut. Shares of the luxury cruise operator closed at $26.10 a share on Wednesday, after opening at $26.15, nearly 9% above its initial public ...

Viking Therapeutics (NASDAQ: VKTX) didn't exactly capture investors' hearts in the final month of 2024. The biotech company's share price eroded by 24% in December, primarily on the back of a ...

Viking Therapeutics (NASDAQ: VKTX) is a hot biotech stock thanks to the company's record of reporting good data from its cardiometabolic disease programs, and there's no sign of that reputation ...

Hansoh Pharma grants Merck global rights to develop and commercialize HS-10535 for weight loss. William Blair maintains Viking Therapeutics as a top 2025 pick, citing VK2735’s potential in ...

Viking Therapeutics, Structure Therapeutics Positioned As Key Pharma Partners For Weight Loss Products: Analyst JPMorgan highlights valuation resets for Viking and Structure Therapeutics, citing ...

The data released by Viking showed that adults taking the highest dosage of the oral VK2735 tablet lost an average of 8.2% of their body weight in just four weeks, or 6.8% more than those that ...

Viking Therapeutics, Inc. (VKTX) closed at $42.53 in the latest trading session, marking a -0.84% move from the prior day. The stock fell short of the S&P 500, which registered a gain of 0.55% for ...

On Thursday, Viking Holdings (NYSE:VIK) received a favorable outlook from a Citi analyst who initiated coverage with a Buy rating and a $54 price target. The analyst provided a positive assessment ...

The latest trading session saw Viking Therapeutics, Inc. (VKTX) ending at $47.03, denoting a -1.75% adjustment from its last day's close. Meanwhile, the Dow experienced a drop of 0.2%, and the ...